Aerovate Therapeutics Inc... (AVTE)
NASDAQ: AVTE
· Real-Time Price · USD
2.68
0.00 (0.00%)
At close: Apr 28, 2025, 3:59 PM
Aerovate Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -252.81 | -122.18 | -32.51 | -17.27 | -322.56 | -268.65 | -167.77 | -198.51 | -283.94 | -420.03 | -272.41 | -283.72 | -362.47 | -306.24 | -709.04 | -8.41 | -1.55K |
PEG Ratio | 4.80 | 1.85 | 0.93 | -4.78 | -26.52 | -63.58 | 25.50 | -8.79 | -173.21 | -47.04 | -19.07 | -31.92 | -11.2 | -9.95 | 7.17 | -0.00 | 15.63 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | 161.29K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 33.93 | 34.72 | 26.23 | 18.13 | 329.09 | 200.41 | 104.42 | 106.44 | 154.67 | 199.13 | 101.99 | 88.41 | 96.70 | 58.42 | 97.52 | -9 | -1.07K |
P/FCF Ratio | -1.07K | -240.22 | -131.6 | -83.74 | -1.26K | -1.48K | -839.23 | -1.01K | -1.53K | -1.7K | -1.46K | -1.48K | -2.75K | -764.38 | -2.66K | -48.5 | -4.52K |
P/OCF Ratio | -1.07K | -240.22 | -131.6 | -83.74 | -1.26K | -1.48K | -840.95 | -1.01K | -1.53K | -1.7K | -1.46K | -1.5K | -2.77K | -769.34 | -2.69K | -48.5 | -4.57K |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -108.82 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | n/a | n/a |
Quick Ratio | 32.01 | 20.93 | 8.78 | 6.51 | 6.65 | 7.04 | 9.34 | 11.48 | 11.33 | 16.90 | 18.84 | 40.85 | 35.27 | 68.37 | 47.87 | 14.14 | 5.39 |
Current Ratio | 32.01 | 20.93 | 8.78 | 6.51 | 6.65 | 7.04 | 9.34 | 11.48 | 11.33 | 16.90 | 18.84 | 40.85 | 35.27 | 68.37 | 47.87 | 14.14 | 5.39 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -127.2 | n/a | n/a | n/a |
Return on Equity | -0.03 | -0.07 | -0.2 | -0.26 | -0.26 | -0.19 | -0.16 | -0.13 | -0.14 | -0.12 | -0.09 | -0.08 | -0.07 | -0.05 | -0.03 | 0.27 | 0.17 |
Return on Assets | -0.03 | -0.07 | -0.18 | -0.22 | -0.22 | -0.16 | -0.14 | -0.12 | -0.12 | -0.11 | -0.09 | -0.08 | -0.06 | -0.05 | -0.03 | -0.09 | -0.28 |
Return on Invested Capital | -0.04 | -0.08 | -0.21 | -0.27 | -0.27 | -0.2 | -0.17 | -0.14 | -0.14 | -0.12 | -0.1 | -0.08 | -0.07 | -0.05 | -0.03 | -0.1 | -0.34 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | -0.21 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -150.1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -149.68 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -162.25 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -162.04 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |